Evaluation of etiology and pregnancy outcome in recurrent miscarriage patients
- PMID: 32994741
- PMCID: PMC7499272
- DOI: 10.1016/j.sjbs.2020.06.049
Evaluation of etiology and pregnancy outcome in recurrent miscarriage patients
Abstract
The purpose of this study was to evaluate etiology and pregnancy outcome of recurrent miscarriage women. The enrolled patients (280) were evaluated for Triiodothyronine, Thyroxine, Thyroid stimulating hormone, prolactin, chromosomal analysis, Haemoglobin A1C, blood sugar, Magnetic resonance imaging, 3D-ultrasound, auto-antibodies profile (antiphospholipid antibodies, anticardiolipin antibodies, lupus anticoagulant, antinuclear antibodies, anti-thyroid antibodies and β2 glycoprotein1), torch profile (Toxoplasmo gondii, rubella, cytomegalo virus and herpes simplex virus), blood vitamin D3 levels, psychological factors, Body mass index and thrombotic factors (protein S and C deficiency, Prothrombin G20210A mutation, anti-thrombin III, Factor V Leiden and Methylenetetrahydrofolate reductase mutation), uterosalpingography (hysteronsalpingography) and hysteroscopy. The therapeutic regimens either singly or combined were employed for the treatment of recurrent miscarriage patients on the basis of etiology (single or multiple) and include intravenous immunoglobulin, low molecular weight heparin, low dose aspirin, levothyroxine, progesterone, folic acid, human chorionic gonadotrophin, vitamin D3, psychotherapy, genetic counselling. However, patients with idiopathic recurrent miscarriage were treated with progesterone supplementation, anticoagulation and/or immune modulatory agents. The incidence of primary recurrent miscarriage was highest and most of the women experienced recurrent miscarriage during first trimester. Endocrinological disorders (39%) were found as the major pathological factor for recurrent miscarriage. Other factors include uterine abnormalities (5.7%), vitamin D3 deficiency (3.5%), psychological factors (3.2%) infection (3.6%), autoimmune abnormalities (1.8%) and protein S deficiency (1.8%). However, 40% cases were idiopathic. The overall live birth rate achieved after the management of recurrent miscarriage patients was 75.7%. Enocrinopathy was the major cause of recurrent miscarriage. The overall live birth rate achieved was 75.7% with highest pregnancy outcome in secondary recurrent miscarriage patients after the management.
Keywords: Enocrinopathy; Etiology; Management; Pregnancy; Pregnancy outcome; Recurrent miscarriage.
© 2020 The Authors.
Figures



Similar articles
-
Recurrent MiscarriageGreen-top Guideline No. 17.BJOG. 2023 Nov;130(12):e9-e39. doi: 10.1111/1471-0528.17515. Epub 2023 Jun 19. BJOG. 2023. PMID: 37334488
-
Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: the PREGNANTS study.Am J Obstet Gynecol. 2017 May;216(5):525.e1-525.e12. doi: 10.1016/j.ajog.2017.01.026. Epub 2017 Jan 30. Am J Obstet Gynecol. 2017. PMID: 28153662
-
Recurrent pregnancy loss evaluation combined with 24-chromosome microarray of miscarriage tissue provides a probable or definite cause of pregnancy loss in over 90% of patients.Hum Reprod. 2018 Apr 1;33(4):579-587. doi: 10.1093/humrep/dey021. Hum Reprod. 2018. PMID: 29538673
-
Thrombophilias and recurrent miscarriage.Obstet Gynecol Surv. 2002 Oct;57(10):703-9. doi: 10.1097/00006254-200210000-00024. Obstet Gynecol Surv. 2002. PMID: 12368598 Review.
-
Anticoagulant therapy and pregnancy.Reprod Med Biol. 2008 Feb 1;7(1):1-10. doi: 10.1111/j.1447-0578.2007.00195.x. eCollection 2008 Mar. Reprod Med Biol. 2008. PMID: 29662414 Free PMC article. Review.
Cited by
-
Prevalence and associated factors of recurrent pregnancy loss in Nigeria according to different national and international criteria (ASRM/ESHRE vs. WHO/RCOG).Front Reprod Health. 2023 Feb 21;5:1049711. doi: 10.3389/frph.2023.1049711. eCollection 2023. Front Reprod Health. 2023. PMID: 36895657 Free PMC article.
-
Immunogenetic Role of IL17A Polymorphism in the Pathogenesis of Recurrent Miscarriage.J Clin Med. 2022 Dec 15;11(24):7448. doi: 10.3390/jcm11247448. J Clin Med. 2022. PMID: 36556060 Free PMC article.
-
Recurrent Pregnancy Loss Etiology, Risk Factors, Diagnosis, and Management. Fresh Look into a Full Box.J Clin Med. 2023 Jun 15;12(12):4074. doi: 10.3390/jcm12124074. J Clin Med. 2023. PMID: 37373766 Free PMC article. Review.
-
Research hotspots and trends in unexplained recurrent spontaneous abortion (URSA) from 2014 to 2024: a bibliometric analysis.Front Med (Lausanne). 2025 May 14;12:1554875. doi: 10.3389/fmed.2025.1554875. eCollection 2025. Front Med (Lausanne). 2025. PMID: 40438372 Free PMC article.
-
Genetic Factors of Idiopathic Recurrent Miscarriage in Kazakh Population.J Reprod Infertil. 2022 Jan-Mar;23(1):39-45. doi: 10.18502/jri.v23i1.8451. J Reprod Infertil. 2022. PMID: 36045885 Free PMC article.
References
-
- Babker A.M., Elzaki S.G., Dafallah S.E. An observational study of causes of recurrent spontaneous abortion among Sudanese women. Int. J. Sci. Res. 2013;4:1435–1438.
LinkOut - more resources
Full Text Sources